Sagility Limited (NSE:SAGILITY) filed a Regulation 30 disclosure on 10 August 2026, notifying exchanges that company officials will participate in the Emkay Confluence 2026 investor conference, titled "India: Full Throttle Ahead," at Grand Hyatt, Mumbai, on Thursday, 13 August 2026, in both group and one-to-one meeting formats.
Key Highlights
- Sagility Limited filed the investor conference schedule with NSE and BSE on 10 August 2026 under Regulation 30 of the SEBI LODR Regulations, 2015.
- Company officials will attend Emkay Confluence 2026 at Grand Hyatt, Mumbai, on 13 August 2026, in group and one-to-one meeting formats.
- The company confirmed that only information already in the public domain will be discussed, and no unpublished price-sensitive information will be shared during the session.
- The meeting schedule is subject to change due to exigencies, as noted in the filing submitted by Company Secretary Satishkumar Sakharayapattana Seetharamaiah.
About the Company
Sagility Limited (NSE:SAGILITY), formerly Sagility India Limited, is a Bengaluru-headquartered technology-enabled services company focused exclusively on the United States healthcare sector. The company provides business process management and technology solutions to healthcare payers and providers, operating across claim processing, clinical management, and revenue cycle services. It is listed on both NSE and BSE under scrip code 544282.
Announcement in Detail
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sagility Limited notified the National Stock Exchange and BSE Limited that its officials will attend the Emkay Confluence 2026 conference, themed "India: Full Throttle Ahead," scheduled for Thursday, 13 August 2026, at Grand Hyatt, Mumbai. The format includes both group sessions and one-to-one meetings with institutional investors and analysts.
The company explicitly stated in the filing that discussions during the conference will be confined to industry-specific and company-specific developments that are already available in the public domain. The filing, signed by Company Secretary and Compliance Officer Satishkumar Sakharayapattana Seetharamaiah (ACS: 16008), further noted that the published schedule remains subject to modification should any unforeseen exigencies arise prior to or on the day of the event.
Impact on Investors
Investors will note that this filing is a procedural compliance disclosure required under SEBI's LODR framework whenever a listed company's representatives attend investor conferences. The filing shows that no unpublished price-sensitive information is to be shared, which means the event does not constitute a selective disclosure event and carries no asymmetric information risk for retail shareholders under the terms stated in the announcement.
Shareholders will observe that Sagility's participation in a prominent institutional investor conference such as Emkay Confluence 2026 reflects its ongoing engagement with the analyst and investor community. The disclosed terms indicate no corporate action, financial result, or strategic decision is being announced through this meeting.
Sector / Market Context
India's healthcare IT and business process outsourcing sector has expanded steadily, driven by demand from United States payers and providers seeking cost-efficient back-office and clinical process support. NASSCOM data consistently places healthcare-focused BPM among the faster-growing verticals within India's broader IT-BPM export industry. Institutional investor conferences of this nature serve as a regulated channel for listed companies in this segment to communicate established operational updates to the analyst community without breaching SEBI's fair disclosure norms.